Drug Information

Drug General Information
Drug ID
D0VY9K
Former ID
DNC010481
Drug Name
2-(N-Pyrrolidinyl)-3'-nitropropiophenone
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530728]
Formula
C14H18N2O3
Canonical SMILES
CC(C(=O)C1=CC(=CC=C1)[N+](=O)[O-])N2CCCCC2
InChI
1S/C14H18N2O3/c1-11(15-8-3-2-4-9-15)14(17)12-6-5-7-13(10-12)16(18)19/h5-7,10-11H,2-4,8-9H2,1H3
InChIKey
LTLFRBMKBHQUTH-UHFFFAOYSA-N
PubChem Compound ID
45141809
Target and Pathway
Target(s) Sodium-dependent dopamine transporter Target Info Inhibitor [530728]
Sodium-dependent noradrenaline transporter Target Info Inhibitor [530728]
KEGG Pathway Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Amphetamine addiction
Alcoholism
PANTHER Pathway Adrenaline and noradrenaline biosynthesis
Parkinson disease
Dopamine receptor mediated signaling pathwayP00001:Adrenaline and noradrenaline biosynthesis
Pathway Interaction Database Alpha-synuclein signaling
Reactome Na+/Cl- dependent neurotransmitter transportersR-HSA-442660:Na+/Cl- dependent neurotransmitter transporters
WikiPathways Monoamine Transport
NRF2 pathway
Dopaminergic Neurogenesis
Parkinsons Disease Pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
Neurotransmitter Clearance In The Synaptic CleftWP727:Monoamine Transport
References
Ref 530728J Med Chem. 2010 Mar 11;53(5):2204-14.Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.
Ref 530728J Med Chem. 2010 Mar 11;53(5):2204-14.Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.